Somerset Trust Co Has $1.78 Million Position in Walgreens Boots Alliance Inc (WBA)

Somerset Trust Co lifted its stake in shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) by 19.2% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 24,503 shares of the pharmacy operator’s stock after purchasing an additional 3,952 shares during the quarter. Somerset Trust Co’s holdings in Walgreens Boots Alliance were worth $1,779,000 as of its most recent SEC filing.

Other large investors also recently added to or reduced their stakes in the company. Pathstone Family Office LLC increased its stake in Walgreens Boots Alliance by 226.6% in the 2nd quarter. Pathstone Family Office LLC now owns 1,179 shares of the pharmacy operator’s stock worth $1,969,000 after acquiring an additional 818 shares during the last quarter. Hudock Capital Group LLC increased its stake in Walgreens Boots Alliance by 0.5% in the 2nd quarter. Hudock Capital Group LLC now owns 1,306 shares of the pharmacy operator’s stock worth $102,000 after acquiring an additional 6 shares during the last quarter. Westside Investment Management Inc. increased its stake in Walgreens Boots Alliance by 10.4% in the 2nd quarter. Westside Investment Management Inc. now owns 1,325 shares of the pharmacy operator’s stock worth $102,000 after acquiring an additional 125 shares during the last quarter. Zions Bancorporation increased its stake in Walgreens Boots Alliance by 983.3% in the 3rd quarter. Zions Bancorporation now owns 1,365 shares of the pharmacy operator’s stock worth $105,000 after acquiring an additional 1,239 shares during the last quarter. Finally, Bristlecone Advisors LLC bought a new position in Walgreens Boots Alliance in the 3rd quarter worth about $135,000. Institutional investors own 61.20% of the company’s stock.

WBA has been the topic of a number of research analyst reports. Morgan Stanley lowered Walgreens Boots Alliance from an “overweight” rating to an “equal weight” rating and decreased their target price for the stock from $95.00 to $85.00 in a research note on Friday, October 6th. BidaskClub upgraded Walgreens Boots Alliance from a “strong sell” rating to a “sell” rating in a research note on Friday, November 10th. Vetr upgraded Walgreens Boots Alliance from a “buy” rating to a “strong-buy” rating in a research note on Tuesday, December 12th. Robert W. Baird restated an “outperform” rating and issued a $80.00 target price (down from $90.00) on shares of Walgreens Boots Alliance in a research note on Thursday, October 19th. They noted that the move was a valuation call. Finally, Citigroup decreased their target price on Walgreens Boots Alliance from $95.00 to $81.00 and set a “buy” rating on the stock in a research note on Thursday, November 2nd. Nine equities research analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and one has issued a strong buy rating to the company’s stock. Walgreens Boots Alliance currently has a consensus rating of “Buy” and a consensus target price of $86.35.

Walgreens Boots Alliance Inc (WBA) opened at $76.47 on Monday. Walgreens Boots Alliance Inc has a fifty-two week low of $63.82 and a fifty-two week high of $88.00. The company has a quick ratio of 0.47, a current ratio of 0.96 and a debt-to-equity ratio of 0.48. The stock has a market capitalization of $75,730.00, a PE ratio of 21.12, a PEG ratio of 1.29 and a beta of 1.22.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its earnings results on Thursday, January 4th. The pharmacy operator reported $1.28 earnings per share for the quarter, beating the consensus estimate of $1.27 by $0.01. The company had revenue of $30.74 billion during the quarter, compared to analysts’ expectations of $30.39 billion. Walgreens Boots Alliance had a return on equity of 19.15% and a net margin of 3.19%. Walgreens Boots Alliance’s quarterly revenue was up 7.9% compared to the same quarter last year. During the same period in the prior year, the business posted $1.10 EPS. research analysts anticipate that Walgreens Boots Alliance Inc will post 5.71 earnings per share for the current fiscal year.

The business also recently announced a quarterly dividend, which will be paid on Monday, March 12th. Investors of record on Thursday, February 15th will be issued a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a yield of 2.09%. The ex-dividend date is Wednesday, February 14th. Walgreens Boots Alliance’s dividend payout ratio is presently 44.20%.

Walgreens Boots Alliance declared that its board has approved a share repurchase plan on Wednesday, October 25th that allows the company to buyback $1.00 billion in shares. This buyback authorization allows the pharmacy operator to reacquire shares of its stock through open market purchases. Shares buyback plans are generally a sign that the company’s board of directors believes its stock is undervalued.

In related news, Director John Anthony Lederer bought 20,000 shares of the company’s stock in a transaction that occurred on Thursday, October 26th. The stock was bought at an average cost of $67.00 per share, for a total transaction of $1,340,000.00. Following the acquisition, the director now directly owns 50,000 shares of the company’s stock, valued at approximately $3,350,000. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director William C. Foote sold 2,736 shares of the stock in a transaction dated Thursday, November 2nd. The shares were sold at an average price of $67.37, for a total value of $184,324.32. Following the sale, the director now owns 16,415 shares of the company’s stock, valued at $1,105,878.55. The disclosure for this sale can be found here. Corporate insiders own 14.80% of the company’s stock.

COPYRIGHT VIOLATION WARNING: “Somerset Trust Co Has $1.78 Million Position in Walgreens Boots Alliance Inc (WBA)” was reported by StockNewsTimes and is owned by of StockNewsTimes. If you are reading this piece of content on another site, it was stolen and reposted in violation of United States & international trademark and copyright laws. The original version of this piece of content can be read at https://stocknewstimes.com/2018/01/22/somerset-trust-co-has-1-78-million-position-in-walgreens-boots-alliance-inc-wba.html.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply